Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$40.95M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	1.56M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	128,734
Open	26.36
Previous Close	26.33
Day's Range	25.88 - 26.43
52-Week Low	9.60
52-Week High	28.44
Beta	n/a
Holdings	10
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

100.00% of assets

Name	Symbol	Weight
ELI LILLY & CO SWAP MS	n/a	45.36%
ELI LILLY & CO SWAP Cantor - L	n/a	36.26%
ELI LILLY & CO SWAP CS	n/a	35.77%
ELI LILLY & CO SWAP MAREX	n/a	30.43%
OTHER ASSETS AND LIABILITIES	n/a	28.02%
ELI LILLY & CO SWAP BMO	n/a	26.30%
LLY SWAP NOMURA	n/a	24.98%
US DOLLARS	n/a	22.22%
United States Treasury Bills 0%	B.0 01.15.26	0.84%
Cash Offset	n/a	-150.19%

Performance

LLYX had a total return of 36.64% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.11%.